In 2023, during Bidens Presidency, the Food and Drug Administration placed nineteen peptides, including BPC-157, on a do not compound list, citing potential significant safety risks that included immune reactions, pancreatitis, and accelerated growth of cancerous cells
It removes water, rendering the molecule stable for transport and storage
For semaglutide, the prescribing information says steady-state exposure is reached after four to five weeks of once-weekly dosing
Neuropsychopharmacol 111
~6 days Retatrutide Half-Life 4 to 5 wks Time to Steady State 2 mg Clinical Starting Dose 12 mg Maximum Phase 2 Dose Investigational status: Retatrutide (LY3437943) is an investigational drug from Eli Lilly
GLP products face insurance coverage barriers In Wisconsin, about 1.6 million adults are living with obesity, according to the American Diabetes Association, and more than 400,000 people are living with diabetes